SEPTERNA INC (SEPN)

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases Phase 1 Clinical...

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era...

Septerna Shares Jump 42% After IPO Shows Biotech Still Hot

Septerna Inc. shares soared as much as 42% in their trading debut after the biotechnology company raised $288 million in an enlarged initial public offering.

Septerna Prices Upsized Initial Public Offering

Septerna Prices Upsized Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era...